These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36687173)

  • 1. Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report.
    Kim S; Sun JH; Kim H; Kim HK; Yang Y; Lee JS; Choi IA; Han HS
    World J Clin Cases; 2023 Jan; 11(1):218-224. PubMed ID: 36687173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report.
    Yang Y; Huang XJ
    World J Clin Cases; 2022 Oct; 10(29):10701-10707. PubMed ID: 36312471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
    Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
    Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
    Mease PJ; Armstrong AW
    Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitor-induced refractory polyarthritis rapidly improved by sarilumab and monitoring with joint ultrasonography: A case report.
    Abe K; Ishikawa Y; Fujiwara M; Yukawa H; Yanagihara T; Takei S; Arioka H; Kita Y
    Medicine (Baltimore); 2022 Jan; 101(2):e28428. PubMed ID: 35029182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
    Kostine M; Rouxel L; Barnetche T; Veillon R; Martin F; Dutriaux C; Dousset L; Pham-Ledard A; Prey S; Beylot-Barry M; Daste A; Gross-Goupil M; Lallier J; Ravaud A; Forcade E; Bannwarth B; Truchetet ME; Richez C; Mehsen N; Schaeverbeke T;
    Ann Rheum Dis; 2018 Mar; 77(3):393-398. PubMed ID: 29146737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
    Hines J; Daily E; Pham AK; Shea CR; Nadeem U; Husain AN; Stadler WM; Reid P
    J Med Case Rep; 2021 Mar; 15(1):124. PubMed ID: 33736690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis.
    Verspohl SH; Holderried T; Behning C; Brossart P; Schäfer VS
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211006963. PubMed ID: 33912248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical application of etanercept in Chinese patients with rheumatic diseases.
    Chou CT
    Mod Rheumatol; 2006; 16(4):206-13. PubMed ID: 16906369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study.
    Gómez-Puerta JA; Lobo-Prat D; Perez-García C; Ponce A; Frade-Sosa B; Millán Arciniegas AM; Ojeda F; Ruiz-Esquide V; Corominas H
    Front Med (Lausanne); 2022; 9():888377. PubMed ID: 35783644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study.
    Cheleschi S; Tenti S; Bedogni G; Fioravanti A
    Transl Res; 2022 Jan; 239():18-34. PubMed ID: 34380068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].
    García C; Arellano J; Vera V; Corredoira Y
    Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.
    Walsh JA; Gottlieb AB; Hoepken B; Nurminen T; Mease PJ
    Clin Rheumatol; 2018 Dec; 37(12):3285-3296. PubMed ID: 30191421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma.
    Kobak S
    Curr Drug Saf; 2019; 14(3):225-229. PubMed ID: 31132977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving recognition of psoriatic arthritis.
    Conaghan PG; Coates LC
    Practitioner; 2009 Dec; 253(1724):15-8, 2-3. PubMed ID: 20120827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic arthritis: a retrospective study of 162 patients.
    Pavlica L; Perić-Hajzler Z; Jovelić A; Sekler B; Damjanović M
    Vojnosanit Pregl; 2005 Sep; 62(9):613-20. PubMed ID: 16229202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatic manifestations of psoriasis.
    Sadek HA; Abdel-Nasser AM; El-Amawy TA; Hassan SZ
    Clin Rheumatol; 2007 Apr; 26(4):488-98. PubMed ID: 16670829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.